Pillars4Life Trial
This study aims to explore whether cancer patients can benefit from completing the Pillars4Life online coping program. This randomized control trial will have half its subject completing the program and the other half receiving standard care in order to measure whether the program is beneficial in dealing with stress, anxiety, and particularly chronic pain that often accompany a cancer diagnosis.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Jul 2, 2017 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Duke University
- Interventions being studied
- Behavioral: Pillars4Life
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Current pain level ≥3 and at least one prior score ≥3 on a 0-10 scale as reported in EPIC;
- Age ≥18 years
- Diagnosed with Breast, GI, GU, GYN, or Thoracic cancer
- Actively receiving care at the Duke Cancer Center, Durham Regional Hospital, or Duke Raleigh Hospital
- Able/willing to have an online interaction with the Pillars4Life online CORE program curriculum
- Life expectancy ≥6 months
- Providing informed consent
- Able to read/write English.
none
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Duke University Medical CenterDurham, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 2, 2017. Always confirm current availability with the study team.